Citadel Advisors - ANPAC BIO MED SCIENCE CO LTD ownership

Back to all holdings Add to watchlist

ANPAC BIO MED SCIENCE CO LTD's ticker is ANPC and the CUSIP is 03635R107. A total of 13 filers reported holding ANPAC BIO MED SCIENCE CO LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Citadel Advisors ownership history of ANPAC BIO MED SCIENCE CO LTD
ValueSharesWeighting
Q1 2022$164,000
+1071.4%
373,615
+3066.2%
0.00%–
Q4 2021$14,000
-80.8%
11,800
-31.7%
0.00%–
Q2 2021$73,000
-51.7%
17,284
-31.2%
0.00%–
Q1 2021$151,000–25,129–0.00%–
 Download
Other shareholders
ANPAC BIO MED SCIENCE CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
HBK Sorce Advisory LLC 19,126$81,0000.00%
TWO SIGMA SECURITIES, LLC 15,677$66,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 116,628$491,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 17,284$73,0000.00%
Tower Research Capital LLC (TRC) 1,177$5,0000.00%
UBS Group AG 2,765$12,0000.00%
View complete list of ANPAC BIO MED SCIENCE CO LTD shareholders